Trinity Biotech has appointed Jerry Lydon as Head of North America Commercial Operations to drive revenue growth and profitability following its Comprehensive Transformation Plan. The company reported Q4 2025 revenues of $11.1 million with improved gross margins, despite a year-on-year revenue decline due to market disruptions and manufacturing adjustments. Lydon will oversee commercial execution, including new product launches like EpiCapture and PrePsia, supporting the company’s focus on operational efficiency and innovation. Trinity continues to scale outsourced manufacturing and aims for sustainable financial improvements in its core diagnostics business.
After the US and Iran reached a deal expected to reopen the Strait of Hormuz, the world's largest tanker owner, Mitsui OSK Lines, cautions that shipping companies will wait for proof the agreement works before resuming normal traffic. The strait is c...
YieldMax ETFs have announced their weekly distributions for Group 1 ETFs, with distribution rates ranging from about 25% to over 65%. These ETFs focus on option income strategies across sectors like semiconductors, AI, crypto, and metals. Investors s...
QTREX Quantum Ltd announced that its Additively Manufactured Electronics (AME) technology achieved a 97% yield validation at a major U.S. interconnect manufacturer. This milestone confirms the technology's readiness for high-demand production environ...
Clean Energy Fuels Corp. secured contracts to design and install liquefied natural gas (LNG) fueling systems in Puerto Rico, supporting a pharmaceutical manufacturer and P.R. Energy Partners' luxury residential and hotel operations. These projects wi...
Epson introduced the WorkForce Enterprise AM-C10000, a high-speed color multifunction printer capable of printing 100 ISO pages per minute, designed for busy offices and print services requiring precise color control. It supports heavy workloads with...
